Teva Pharmaceutical Industries Ltd ADR buy Truist Financial Co.
Start price
18.02.26
/
50%
€28.90
Target price
18.02.27
€35.46
Performance (%)
-4.50%
Price
17.04.26
€27.60
Summary
This prediction is currently active. With a performance of -4.50%, the BUY prediction for Teva Pharmaceutical Industries Ltd ADR by Truist_Financial_Co_ is down slightly. This prediction currently runs until 18.02.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 4.943% | 4.943% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $38.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€27.00
29.01.26
29.01.26
€31.75
29.01.27
29.01.27
2.22%
17.04.26
17.04.26
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.95
28.05.25
28.05.25
€22.09
28.05.26
28.05.26
73.04%
17.04.26
17.04.26